SPORTRADAR GROUP AG-A (SRAD) Fundamental Analysis & Valuation

NASDAQ:SRAD • CH1134239669

Current stock price

18.57 USD
-0.73 (-3.78%)
Last:

This SRAD fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. SRAD Profitability Analysis

1.1 Basic Checks

  • SRAD had positive earnings in the past year.
  • SRAD had a positive operating cash flow in the past year.
  • Each year in the past 5 years SRAD has been profitable.
  • SRAD had a positive operating cash flow in each of the past 5 years.
SRAD Yearly Net Income VS EBIT VS OCF VS FCFSRAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

1.2 Ratios

  • SRAD has a better Return On Assets (3.49%) than 60.32% of its industry peers.
  • Looking at the Return On Equity, with a value of 10.25%, SRAD is in the better half of the industry, outperforming 70.63% of the companies in the same industry.
  • SRAD has a Return On Invested Capital of 4.64%. This is comparable to the rest of the industry: SRAD outperforms 46.03% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for SRAD is significantly below the industry average of 10.61%.
Industry RankSector Rank
ROA 3.49%
ROE 10.25%
ROIC 4.64%
ROA(3y)2.17%
ROA(5y)1.6%
ROE(3y)5.98%
ROE(5y)4.22%
ROIC(3y)4.69%
ROIC(5y)3.82%
SRAD Yearly ROA, ROE, ROICSRAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • SRAD has a Profit Margin of 7.78%. This is in the better half of the industry: SRAD outperforms 69.05% of its industry peers.
  • SRAD's Profit Margin has improved in the last couple of years.
  • SRAD has a Operating Margin (9.79%) which is in line with its industry peers.
  • SRAD's Operating Margin has declined in the last couple of years.
  • SRAD has a Gross Margin of 77.73%. This is amongst the best in the industry. SRAD outperforms 90.48% of its industry peers.
  • SRAD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 9.79%
PM (TTM) 7.78%
GM 77.73%
OM growth 3Y40.27%
OM growth 5Y-5.57%
PM growth 3Y73.36%
PM growth 5Y15.68%
GM growth 3Y3.93%
GM growth 5Y1.8%
SRAD Yearly Profit, Operating, Gross MarginsSRAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. SRAD Health Analysis

2.1 Basic Checks

  • SRAD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for SRAD remains at a similar level compared to 1 year ago.
  • SRAD has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for SRAD is higher compared to a year ago.
SRAD Yearly Shares OutstandingSRAD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
SRAD Yearly Total Debt VS Total AssetsSRAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.2 Solvency

  • An Altman-Z score of 2.38 indicates that SRAD is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • The Altman-Z score of SRAD (2.38) is better than 64.29% of its industry peers.
  • The Debt to FCF ratio of SRAD is 0.36, which is an excellent value as it means it would take SRAD, only 0.36 years of fcf income to pay off all of its debts.
  • SRAD's Debt to FCF ratio of 0.36 is amongst the best of the industry. SRAD outperforms 92.06% of its industry peers.
  • SRAD has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
  • SRAD has a better Debt to Equity ratio (0.05) than 83.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.36
Altman-Z 2.38
ROIC/WACC0.75
WACC6.15%
SRAD Yearly LT Debt VS Equity VS FCFSRAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.3 Liquidity

  • SRAD has a Current Ratio of 1.17. This is a normal value and indicates that SRAD is financially healthy and should not expect problems in meeting its short term obligations.
  • SRAD has a Current ratio of 1.17. This is in the better half of the industry: SRAD outperforms 61.11% of its industry peers.
  • A Quick Ratio of 1.17 indicates that SRAD should not have too much problems paying its short term obligations.
  • With a decent Quick ratio value of 1.17, SRAD is doing good in the industry, outperforming 63.49% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.17
Quick Ratio 1.17
SRAD Yearly Current Assets VS Current LiabilitesSRAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

8

3. SRAD Growth Analysis

3.1 Past

  • SRAD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 272.73%, which is quite impressive.
  • Measured over the past years, SRAD shows a very strong growth in Earnings Per Share. The EPS has been growing by 44.42% on average per year.
  • SRAD shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.57%.
  • The Revenue has been growing by 26.08% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)272.73%
EPS 3Y108.86%
EPS 5Y44.42%
EPS Q2Q%483.33%
Revenue 1Y (TTM)16.57%
Revenue growth 3Y20.89%
Revenue growth 5Y26.08%
Sales Q2Q%20.13%

3.2 Future

  • Based on estimates for the next years, SRAD will show a very strong growth in Earnings Per Share. The EPS will grow by 27.23% on average per year.
  • The Revenue is expected to grow by 13.29% on average over the next years. This is quite good.
EPS Next Y21.57%
EPS Next 2Y36.98%
EPS Next 3Y27.23%
EPS Next 5YN/A
Revenue Next Year21.58%
Revenue Next 2Y18.24%
Revenue Next 3Y15.26%
Revenue Next 5Y13.29%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SRAD Yearly Revenue VS EstimatesSRAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B
SRAD Yearly EPS VS EstimatesSRAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

3

4. SRAD Valuation Analysis

4.1 Price/Earnings Ratio

  • SRAD is valuated quite expensively with a Price/Earnings ratio of 39.51.
  • The rest of the industry has a similar Price/Earnings ratio as SRAD.
  • The average S&P500 Price/Earnings ratio is at 25.50. SRAD is valued rather expensively when compared to this.
  • With a Price/Forward Earnings ratio of 32.20, SRAD can be considered very expensive at the moment.
  • SRAD's Price/Forward Earnings ratio is in line with the industry average.
  • SRAD is valuated rather expensively when we compare the Price/Forward Earnings ratio to 22.67, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 39.51
Fwd PE 32.2
SRAD Price Earnings VS Forward Price EarningsSRAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SRAD is valued a bit cheaper than 61.11% of the companies in the same industry.
  • SRAD's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 27.47
EV/EBITDA 10.11
SRAD Per share dataSRAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SRAD does not grow enough to justify the current Price/Earnings ratio.
  • SRAD has a very decent profitability rating, which may justify a higher PE ratio.
  • SRAD's earnings are expected to grow with 27.23% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.83
PEG (5Y)0.89
EPS Next 2Y36.98%
EPS Next 3Y27.23%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SRAD Dividend Analysis

5.1 Amount

  • No dividends for SRAD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SRAD Fundamentals: All Metrics, Ratios and Statistics

SPORTRADAR GROUP AG-A

NASDAQ:SRAD (3/25/2026, 2:45:04 PM)

18.57

-0.73 (-3.78%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)03-03
Earnings (Next)05-11
Inst Owners91.91%
Inst Owner Change-1.59%
Ins Owners1.34%
Ins Owner Change0%
Market Cap5.55B
Revenue(TTM)1.29B
Net Income(TTM)100.32M
Analysts82.86
Price Target31.9 (71.78%)
Short Float %5.14%
Short Ratio4.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-49.9%
Min EPS beat(2)-78.56%
Max EPS beat(2)-21.24%
EPS beat(4)2
Avg EPS beat(4)113.82%
Min EPS beat(4)-78.56%
Max EPS beat(4)413.81%
EPS beat(8)3
Avg EPS beat(8)54.21%
EPS beat(12)4
Avg EPS beat(12)30.64%
EPS beat(16)7
Avg EPS beat(16)8.93%
Revenue beat(2)0
Avg Revenue beat(2)-2.47%
Min Revenue beat(2)-2.99%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-1.67%
Min Revenue beat(4)-2.99%
Max Revenue beat(4)-0.42%
Revenue beat(8)4
Avg Revenue beat(8)1.19%
Revenue beat(12)4
Avg Revenue beat(12)-0.47%
Revenue beat(16)8
Avg Revenue beat(16)0.37%
PT rev (1m)-1.95%
PT rev (3m)-3.9%
EPS NQ rev (1m)-20.95%
EPS NQ rev (3m)-23.39%
EPS NY rev (1m)0.24%
EPS NY rev (3m)-0.86%
Revenue NQ rev (1m)-2.66%
Revenue NQ rev (3m)-2.69%
Revenue NY rev (1m)-0.5%
Revenue NY rev (3m)-0.44%
Valuation
Industry RankSector Rank
PE 39.51
Fwd PE 32.2
P/S 3.72
P/FCF 27.47
P/OCF 11.9
P/B 4.9
P/tB N/A
EV/EBITDA 10.11
EPS(TTM)0.47
EY2.53%
EPS(NY)0.58
Fwd EY3.11%
FCF(TTM)0.68
FCFY3.64%
OCF(TTM)1.56
OCFY8.4%
SpS4.99
BVpS3.79
TBVpS-4.09
PEG (NY)1.83
PEG (5Y)0.89
Graham Number6.33
Profitability
Industry RankSector Rank
ROA 3.49%
ROE 10.25%
ROCE 5.49%
ROIC 4.64%
ROICexc 5.52%
ROICexgc N/A
OM 9.79%
PM (TTM) 7.78%
GM 77.73%
FCFM 13.54%
ROA(3y)2.17%
ROA(5y)1.6%
ROE(3y)5.98%
ROE(5y)4.22%
ROIC(3y)4.69%
ROIC(5y)3.82%
ROICexc(3y)5.63%
ROICexc(5y)5.08%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.56%
ROCE(5y)4.52%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y28.03%
ROICexc growth 5Y-14.48%
OM growth 3Y40.27%
OM growth 5Y-5.57%
PM growth 3Y73.36%
PM growth 5Y15.68%
GM growth 3Y3.93%
GM growth 5Y1.8%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF 0.36
Debt/EBITDA 0.11
Cap/Depr 67.75%
Cap/Sales 17.71%
Interest Coverage 1.48
Cash Conversion 86.97%
Profit Quality 174.06%
Current Ratio 1.17
Quick Ratio 1.17
Altman-Z 2.38
F-Score6
WACC6.15%
ROIC/WACC0.75
Cap/Depr(3y)80.11%
Cap/Depr(5y)85.9%
Cap/Sales(3y)20.37%
Cap/Sales(5y)21.33%
Profit Quality(3y)236.52%
Profit Quality(5y)154.22%
High Growth Momentum
Growth
EPS 1Y (TTM)272.73%
EPS 3Y108.86%
EPS 5Y44.42%
EPS Q2Q%483.33%
EPS Next Y21.57%
EPS Next 2Y36.98%
EPS Next 3Y27.23%
EPS Next 5YN/A
Revenue 1Y (TTM)16.57%
Revenue growth 3Y20.89%
Revenue growth 5Y26.08%
Sales Q2Q%20.13%
Revenue Next Year21.58%
Revenue Next 2Y18.24%
Revenue Next 3Y15.26%
Revenue Next 5Y13.29%
EBIT growth 1Y-6.15%
EBIT growth 3Y69.57%
EBIT growth 5Y19.05%
EBIT Next Year127.66%
EBIT Next 3Y51.79%
EBIT Next 5Y33.42%
FCF growth 1Y39.3%
FCF growth 3Y216.65%
FCF growth 5Y24.96%
OCF growth 1Y14.17%
OCF growth 3Y33.84%
OCF growth 5Y21.65%

SPORTRADAR GROUP AG-A / SRAD Fundamental Analysis FAQ

What is the fundamental rating for SRAD stock?

ChartMill assigns a fundamental rating of 6 / 10 to SRAD.


Can you provide the valuation status for SPORTRADAR GROUP AG-A?

ChartMill assigns a valuation rating of 3 / 10 to SPORTRADAR GROUP AG-A (SRAD). This can be considered as Overvalued.


How profitable is SPORTRADAR GROUP AG-A (SRAD) stock?

SPORTRADAR GROUP AG-A (SRAD) has a profitability rating of 6 / 10.


What are the PE and PB ratios of SPORTRADAR GROUP AG-A (SRAD) stock?

The Price/Earnings (PE) ratio for SPORTRADAR GROUP AG-A (SRAD) is 39.51 and the Price/Book (PB) ratio is 4.9.


Can you provide the financial health for SRAD stock?

The financial health rating of SPORTRADAR GROUP AG-A (SRAD) is 6 / 10.